2734 Federal Register / Vol. 77, No. 12 / Thursday, January 19, 2012 / Notices 

Written comments and 

recommendations concerning the 

proposed information collection should 

be sent within 30 days of this notice to 

the desk officer for HRSA, either by 

email to 

OIRA_submission@omb.eop.gov or by 

fax to (202) 395–6974. Please direct all 

correspondence to the ‘‘attention of the 

desk officer for HRSA.’’ 

Dated: January 12, 2012. 

Reva Harris, 

Acting Director, Division of Policy and 

Information Coordination. 

[FR Doc. 2012–954 Filed 1–18–12; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Health Information Technology 

Implementation 

AGENCY: Health Resources and Services 

Administration, HHS. 

ACTION: Notice of Noncompetitive 

Replacement Award to Tennessee 

Primary Care Association, Brentwood, 

Tennessee. 

SUMMARY: The Health Resources and 

Services Administration (HRSA) will be 

transferring the American Recovery and 

Reinvestment Act (ARRA) (section 330 

of the Public Health Service Act) Health 

Information Technology 

Implementation for Health Center 

Controlled Networks (HCCN) funds 

originally awarded to Community 

Health Network, Inc. (CHN), to the 

Tennessee Primary Care Association 

(TPCA) to ensure the implementation of 

a Health Center Controlled Network in 

the State of Tennessee. 

SUPPLEMENTARY INFORMATION: 

Former Grantee of Record: 

Community Health Network, Inc. 

Original Period of Grant Support: 

June 1, 2010, to May 31, 2012. 

Replacement Awardee: Tennessee 

Primary Care Association. 

Amount of Replacement Award: 

$1,807,399.60. 

Period of Replacement Award: The 

period of support for the replacement 

award is December 1, 2011, to May 31, 

2012. 

Authority: Section 330 of the Public Health 

Service Act, 42 U.S.C. 245b. 

CFDA Number: 93.703 

Justification for the Exception to 

Competition 

The former grantee (CHN) 

relinquished the grant and its 

responsibilities due to financial 

difficulties as well as management and 

legal concerns. TPCA has been a HRSA 

funded Primary Care Association since 

1985 and is a well established 

organization with sound fiscal and 

grants management operations. 

In the effort to preserve the 

opportunity to advance information 

technology resources of the Tennessee’s 

medically underserved communities, 

TPCA has demonstrated the capacity to 

fulfill the expectations of the original 

grant award and has collaborated with 

CHN’s Board of Directors to plan for a 

smooth transition of the grant. 

The transfer of these funds will 

ensure full implementation of the grant 

which will greatly advance the State of 

Tennessee’s continuity of care and have 

a positive impact on population health. 

It will also help the participating health 

centers to meet requirements for 

Meaningful Use and Patient Centered 

Medical Home programs by the Centers 

for Medicare and Medicaid Services 

(CMS), the National Committee for 

Quality Assurance (NCQA) and/or the 

Joint Commission. 

The implementation of a Health 

Center Controlled Network would assist 

with the advancement and effective use 

of Health Information Technology. 

These advancements will result in 

measurable improvements in patient 

outcomes and reductions of health 

disparities for underserved communities 

in the State of Tennessee. As a result, in 

order to ensure a timely implementation 

of a Health Center Controlled Network 

in the State of Tennessee as originally 

awarded, this replacement award will 

not be competed. 

FOR FURTHER INFORMATION CONTACT: Ms. 

Mayra Nicolas via phone at (301) 594– 

4294 or via email at mnicolas@hrsa.gov. 

Dated: January 10, 2012. 

Mary K. Wakefield, 

Administrator. 

[FR Doc. 2012–964 Filed 1–18–12; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

National Advisory Council on Migrant 

Health; Notice of Meeting 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), notice is hereby given 

of the following meeting: 

Name: National Advisory Council on 

Migrant Health. 

Dates and Times: February 7, 2012, 8:30 

a.m. to 5 p.m.; February 8, 2012, 8:30 a.m. 

to 5 p.m. 

Place: Crystal Gateway Marriott Hotel, 

1700 Jefferson Davis Highway, Arlington, 

Virginia 22202. Telephone: (703) 920–3230. 

Fax: (703) 271–5212. 

Status: The meeting will be open to the 

public. 

Purpose: The purpose of the meeting is to 

discuss services and issues related to the 

health of migrant and seasonal farmworkers 

and their families and to formulate 

recommendations for the Secretary of Health 

and Human Services. 

Agenda: The agenda includes an overview 

of the Council’s general business activities. 

The Council will also hear presentations 

from experts on farmworker issues, including 

the status of farmworker health at the local 

and national levels. 

Agenda items are subject to change as 

priorities indicate. 

FOR FURTHER INFORMATION CONTACT: 

Gladys Cate, Office of Special 

Population Health, Bureau of Primary 

Health Care, Health Resources and 

Services Administration, 5600 Fishers 

Lane, Room 15–62, Rockville, Maryland 

20857; telephone (301) 594–0367. 

Dated: January 12, 2012. 

Reva Harris, 

Acting Director, Division of Policy and 

Information Coordination. 

[FR Doc. 2012–959 Filed 1–18–12; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Proposed Collection; Comment 

Request: Solar Cell: A Mobile UV 

Manager for Smart Phones (NCI) 

SUMMARY: In compliance with the 

requirement of Section 3506(c)(2)(A) of 

the Paperwork Reduction Act of 1995, 

for opportunity for public comment on 

proposed data collection projects, the 

National Cancer Institute (NCI), the 

National Institutes of Health (NIH) will 

publish periodic summaries of proposed 

projects to be submitted to the Office of 

Management and Budget (OMB) for 

review and approval. 

Proposed Collection: Title: Solar Cell: 

A Mobile UV Manager for Smart Phones 

(NCI). Type of Information Collection 

Request: New. Need and Use of 

Information Collection: The overall goal 

of the study is to design a smart phone 

application, Solar Cell, which uses 

smart phone technology to aid users in 

protecting their skin from damaging 

ultraviolet radiation (UV) in sunlight, a 

primary cause of skin cancer. The 

purpose of this part of the study is to 

produce, deploy, and evaluate the 

mstockstill on DSK4VPTVN1PROD with NOTICES

Federal Register / Vol. 77, No. 12 / Thursday, January 19, 2012 / Notices 2735 

effectiveness of a state-of-the-art 

software application for smart phones 

(i.e., mobile application), ‘‘Solar Cell.’’ 

This software application supports 

decision-making related to sun 

protection and exposure by Americans 

to reduce the risk of developing skin 

cancer attributable to chronic and severe 

UV exposure and developing other 

cancers attributable to vitamin D 

deficiency. The Solar Cell mobile smart 

phone application combines personal 

and behavior data with geo-spatial data 

(i.e., UV Index forecast, time, and 

location) and delivers actionable sun 

protection advice to reduce risk of skin 

cancer. Frequency of Response: Once. 

Affected Public: Individuals. Type of 

Respondents: Adults (18 and over) from 

the U.S. population who own Android 

smart phones. The annual reporting 

burden is estimated at 673 (see Table 

below). There are no Capital Costs, 

Operating Costs, and/or Maintenance 

Costs to report. 

A.12–1—ESTIMATES OF ANNUAL BURDEN HOURS

Type of respondents Instrument Number of 

respondents 

Frequency of 

response 

Average time per 

response 

(minutes/hour) 

Annual burden 

hours 

Adults .................................... Screener (Appendix G) ......... 1,875 1 15/60 (0.25) 469 

Pre-test (Appendix A) ........... 245 1 20/60 (0.33) 82 

Post-test (Appendix B) ......... 184 1 40/60 (0.66) 123 

Totals ............................. 2,304 673 

Request for Comments: Written 

comments and/or suggestions from the 

public and affected agencies should 

address one or more of the following 

points: (1) Evaluate whether the 

proposed collection of information is 

necessary for the proper performance of 

the function of the agency, including 

whether the information will have 

practical utility; (2) Evaluate the 

accuracy of the agency’s estimate of the 

burden of the proposed collection of 

information, including the validity of 

the methodology and assumptions used; 

(3) Enhance the quality, utility, and 

clarity of the information to be 

collected; and (4) Minimize the burden 

of the collection of information on those 

who are to respond, including the use 

of appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms of 

information technology. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the data collection plans and 

instruments, contact Patricia Weber, 

DrPH, Program Director, NCI/NIH, SBIR 

Development Center, 6116 Executive 

Blvd., Suite 402, Rockville, MD 20852 

or call non-toll-free number (301) 594– 

8106 or email your request, including 

your address to: weberpa@mail.nih.gov. 

Comments Due Date: Comments 

regarding this information collection are 

best assured of having their full effect if 

received within 60 days of the date of 

this publication. 

Dated: January 11, 2012. 

Vivian Horovitch-Kelley, 

NCI Project Clearance Liaison, National 

Institutes of Health. 

[FR Doc. 2012–872 Filed 1–18–12; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Human Genome Research 

Institute; Notice of Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of meetings of the National 

Advisory Council for Human Genome 

Research. 

The meetings will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications 

and/or contract proposals and the 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with the grant 

applications and/or contract proposals, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Advisory 

Council for Human Genome Research. 

Date: February 13–14, 2012. 

Open: February 13, 2012, 8:30 a.m. to 

3 p.m. 

Agenda: To discuss matters of program 

relevance. 

Place: National Institutes of Health, 5635 

Fishers Lane, Terrace Level Conference 

Room, Rockville, MD 20892. 

Closed: February 13, 2012, 3 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications and/or proposals. 

Place: National Institutes of Health, 5635 

Fishers Lane Terrace Level Conference Room, 

Rockville, MD 20892. 

Closed: February 14, 2012, 8:30 a.m. to 

5 p.m. 

Agenda: To review and evaluate grant 

applications and/or proposals National 

Institutes of Health, 5635 Fishers Lane, 

Terrace Level Conference Room, Rockville, 

MD 20892. 

Contact Person: Mark S. Guyer, Ph.D., 

Director for Extramural Research National 

Human Genome Research Institute, 5635 

Fishers Lane, Suite 4076, MSC 9305, 

Bethesda, MD 20892, (301) 496–7531 

guyerm@mail.nih.gov. 

Name of Committee: National Advisory 

Council for Human Genome Research. 

Date: May 21–22, 2012. 

Open: May 21, 2012, 8:30 a.m. to 3 p.m. 

Agenda: To discuss matters of program 

relevance. 

Place: National Institutes of Health, 5635 

Fishers Lane, Terrace Level Conference 

Room, Rockville, MD 20892. 

Closed: May 21, 2012, 3 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications and/or proposals. 

Place: National Institutes of Health, 5635 

Fishers Lane, Terrace Level Conference 

Room, Rockville, MD 20892. 

Closed:May 22, 2012, 8:30 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications and/or proposals. 

Place: National Institutes of Health, 5635 

Fishers Lane, Terrace Level Conference 

Room, Rockville, MD 20892. 

Contact Person: Mark S. Guyer, Ph.D., 

Director for Extramural Research, National 

Human Genome Research Institute, 5635 

Fishers Lane, Suite 4076, MSC 9305, 

Bethesda, MD 20892, (301) 496–7531, 

guyerm@mail.nih.gov. 

Name of Committee: National Advisory 

Council for Human Genome Research. 

Date: September 10–11, 2012. 

Open: September 10, 2012, 8:30 a.m. to 

3 p.m. 

mstockstill on DSK4VPTVN1PROD with NOTICES